Key result
Women with STEMI undergoing primary PCI have a higher risk of bleeding and MACE compared to men, although increased long-term MACE is driven by baseline comorbidities.
Why the study?
Do women with STEMI undergoing primary PCI have worse clinical outcomes compared to men?
Do women with STEMI undergoing primary PCI have worse clinical outcomes compared to men?
Answers are grounded in this paper and cite their sources.
Female sex is an independent predictor of major bleeding in STEMI patients undergoing primary PCI, highlighting the need for sex-specific cardiovascular risk assessment and tailored antithrombotic regimens.
Key Points Women with STEMI undergoing primary PCI have a higher risk of short‐term and long‐term bleeding and MACE compared to men, although increased long‐term MACE is driven by increased female baseline comorbidities and treatment differences. Female sex is an easily identifiable phenotype that should alert clinicians to perform sex‐specific cardiovascular risk assessment for prevention, recognize female‐pattern angina symptoms, and provide education to reduce the delay between symptom onset and hospital presentation. Female sex remains an independent predictor of major bleeding and additional studies are required to determine female‐specific antithrombotic regimens and catheter‐access protocols.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2015) conducted an editorial in STEMI undergoing primary PCI. Female sex vs. Male sex was evaluated on Short-term and long-term bleeding and MACE. Women with STEMI undergoing primary PCI have a higher risk of bleeding and MACE compared to men, although increased long-term MACE is driven by baseline comorbidities.
Synapse has enriched 10 related papers. Consider them for comparative context: